Back to search
FDAFDA · Food and drugs·Recall number D-600-2013

MAXILOSS Weight Advanced, 225 mg proprietary blend of herbs, supplied in 36 count capsules in Green & Blue Boxes, Formulated and distributed by Olaax Corp, Lakeland, FL

Published June 19, 2013 · Recall initiated: February 12, 2013

Summary

FDA records drug Class I recall D-600-2013, published June 19, 2013 and initiated February 12, 2013. Recalling firm: OLAAX International; Status: Terminated; Reported quantity: 600 boxes; Lot: All Lots. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without an Approved NDA/ANDA: product contains sibutramine, a previously approved FDA drug removed from the U.S. marketplace for safety reasons, making it an unapproved new drug.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
OLAAX International
Distributor
Nationwide, Puerto Rico and Venezuela and Bolivia
Lot
All Lots
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was MAXILOSS Weight Advanced, 225 mg proprietary blend of herbs, supplied in 36 count capsules in Green & Blue Boxes, Formulated and distributed by Olaax Corp, Lakeland, FL recalled?

Yes. FDA published recall D-600-2013 on June 19, 2013. Reported hazard: Marketed Without an Approved NDA/ANDA: product contains sibutramine, a previously approved FDA drug removed from the U.S. marketplace for safety reasons, making it an unapproved new drug.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone